Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FASN | P49327 | 10/20 | 0.80 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.36 |
| ▸ | PLA2G5 | P39877 | 1/20 | 0.36 |
| ▸ | PTGES | O14684 | 2/20 | 0.33 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30212058 | 0.95 | FASN (0.72) | FASNPLA2G2APLA2G5PTGESALOX5 | |
| SCHEMBL30212041 | 0.91 | FASN (0.80) | FASNPLA2G2APLA2G5PTGESALOX5 | |
| SCHEMBL30212063 | 0.89 | FASN (0.70) | FASN | |
| SCHEMBL30212107 | 0.85 | FASN (0.77) | FASNPTGESALOX5 | |
| SCHEMBL30212078 | 0.84 | FASN (0.63) | FASNPLA2G2APLA2G5PTGESALOX5 | |
| SCHEMBL29466102 | 0.84 | FASN (0.91) | FASNPTGESALOX5 | |
| SCHEMBL30212088 | 0.83 | FASN (0.72) | FASNPLA2G2APLA2G5PTGESALOX5 | |
| SCHEMBL1785484 | 0.83 | FASN (0.60) | FASNPLA2G2APLA2G5PTGESALOX5 | |
| SCHEMBL28043703 | 0.83 | FASN (0.89) | FASNPTGESALOX5 | |
| SCHEMBL30212096 | 0.82 | FASN (1.00) | FASN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12178790-B2 | Antibacterial compound isolated from Psiloxylon mauritianum and its derivatives | SORRES, Jonathan (FR) | 2024-12-31 | — | — | US | disclosed |
| US-20240293305-A1 | COMPOSITION WITH ANTIMICROBIAL OR ANTIFUNGAL ACTIVITY COMPRISING FERMENTED SCUTELLARIA BAICALENSIS EXTRACT, FERMENTED SALVIA MILTIORRHIZA EXTRACT AND FERMENTED DRYPTERIS CCRASSIRHIZOMA EXTRACT | SOOY-K CO., LTD. (KR) | 2024-09-05 | — | — | US | disclosed |
| US-20230062900-A1 | NEW ANTIBACTERIAL COMPOUND ISOLATED FROM PSILOXYLON MAURITIANUM AND ITS DERIVATIVES | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 2023-03-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230062900-A1 | NEW ANTIBACTERIAL COMPOUND ISOLATED FROM PSILOXYLON MAURITIANUM AND ITS DERIVATIVES | PNN, AAAS, MRPS35 | FASN 37/4885PLA2G2A 3226/4885PLA2G5 1744/4885 |
| US-12178790-B2 | Antibacterial compound isolated from Psiloxylon mauritianum and its derivatives | AAAS, PNN, MRPL9 | FASN 27/4885PLA2G2A 3357/4885PLA2G5 1955/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.